292-24866-24518
4 vaccinations
2 coded responses
47 check-ins
1 free-text entry
2 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 972 / OR
- Registered
- 2021-01-02
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-02
Registered in v-safe
-
2021-01-02
Dose 1 — Moderna
-
2021-01-02
Health check-in — day 0, dose 1Feeling: Fair · Site: Pain · Chills, Muscle or body aches, NauseaAdult check-in
-
2021-01-03
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Muscle or body achesAdult check-in
- 2021-01-05
- 2021-01-06
- 2021-01-07
- 2021-01-08
- 2021-01-09
-
2021-01-16
Survey response — day 14, dose 1MedDRA: Injection site erythema, Injection site pruritus, Injection site rash, Injection site swelling — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Baseball sized red itchy rash at the vaccination site about a week after the vaccineMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-16
Report sent to call center — day 14, dose 1Get care from a doctor or other healthcare professional1 call case(s)
- 2021-01-23
-
2021-01-29
Dose 2 — Moderna
-
2021-01-30
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Swelling · Chills, Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-01-31
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
- 2021-02-01
- 2021-02-02
- 2021-02-03
- 2021-02-04
- 2021-02-05
- 2021-02-12
- 2021-02-19
- 2021-02-26
- 2021-03-05
- 2021-03-12
-
2021-03-16
Call successfulCompleted over the phone
- 2021-04-30
- 2021-07-30
-
2021-11-04
Dose 3 — Moderna
- 2021-11-04
- 2021-11-05
- 2021-11-06
- 2021-11-07
- 2021-11-08
- 2021-11-09
- 2021-11-10
- 2021-11-11
- 2021-11-18
- 2021-11-25
- 2021-12-02
- 2021-12-09
- 2021-12-16
- 2022-02-03
- 2022-05-05
-
2022-09-09
Dose 4 — Moderna
- 2022-09-13
- 2022-09-16
- 2022-09-23
- 2022-10-01
- 2022-10-07
- 2022-10-14
- 2022-10-21
- 2022-12-09
-
2023-03-10
Survey response — 6 months, dose 4MedDRA: COVID-19 — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationMedDRA releases: 2024-11
-
2023-03-10
Report sent to call center — 6 months, dose 4Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2023-03-13
- 2023-04-06
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-02 | Moderna | |
| 2 | 2021-01-29 | Moderna | |
| 3 | 2021-11-04 | Moderna | No |
| 4 | 2022-09-09 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-16 | Successful 2021-03-16 |
Completed over the phone |
| 2023-03-10 | Unsuccessful |
Free text
Release 2 — day 14, dose 1
Symptoms: Baseball sized red itchy rash at the vaccination site about a week after the vaccine
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Injection site erythema | ✓ | ✓ | ✓ |
| SD | Injection site pruritus | ✓ | ✓ | ✓ |
| SD | Injection site rash | ✓ | ✓ | ✓ |
| SD | Injection site swelling | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release